VolitionRX Limited (VNRX) Financials
VNRX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-03-31 | 19.4 million | 35.6 million |
| 2023-12-31 | 28.0 million | 36.2 million |
| 2023-09-30 | 18.0 million | 20.9 million |
| 2023-06-30 | 27.6 million | 22.4 million |
VNRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-03-31 | -8.4 million | 411220 |
| 2023-12-31 | 6.1 million | 465734 |
| 2023-09-30 | -8.7 million | 537980 |
| 2023-06-30 | -7.6 million | 592174 |
VNRX Net Income
No data available :(
VNRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-03-31 | 11.8 million | - | 1.0 million |
| 2023-12-31 | 20.7 million | - | 1.0 million |
| 2023-09-30 | 10.8 million | - | 960398 |
| 2023-06-30 | 19.7 million | 2.5 million | 1.0 million |
VNRX Shares Outstanding
VNRX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-03-31 | 78809 | 4.4 million | 3.6 million | 251064 |
| 2023-12-31 | 307122 | 4.2 million | 4.0 million | 373340 |
| 2023-09-30 | 273041 | 4.7 million | 3.9 million | 156775 |
| 2023-06-30 | 301394 | 5.5 million | 4.0 million | 254768 |
VNRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-03-31 | 171535 | 322073 |
| 2023-12-31 | 243973 | 362915 |
| 2023-09-30 | 165211 | 362467 |
| 2023-06-30 | 216310 | 351668 |
VNRX
Price: $0.75
52 week price:
Earnings Per Share: -0.50 USD
P/E Ratio: -2.17
Exchange: ASE
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 202636
Market Capitalization: 63.8 million